|
|
Volumn 21, Issue 9, 2000, Pages 704-707
|
|
Percutaneous transluminal septal myocardial ablation: A new treatment for hypertrophic obstructive cardiomyopathy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALCOHOL;
CARDIOVASCULAR AGENT;
ADULT;
ADVERSE DRUG REACTION;
AGED;
ANGIOCARDIOGRAPHY;
ARTIFICIAL HEART PACEMAKER;
CATHETER ABLATION;
ECHOCARDIOGRAPHY;
EDITORIAL;
FOLLOW UP;
HEART ATRIUM ENLARGEMENT;
HEART BLOCK;
HEART INFARCTION;
HEART LEFT VENTRICLE OUTFLOW TRACT;
HEART MUSCLE ISCHEMIA;
HEART RUPTURE;
HEART SEPTUM DEFECT;
HEART VENTRICLE ARRHYTHMIA;
HEMODYNAMICS;
HUMAN;
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY;
MITRAL VALVE REGURGITATION;
MUSCLE RESECTION;
PATIENT MONITORING;
PATIENT SELECTION;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION;
PEROPERATIVE COMPLICATION;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RISK FACTOR;
SUDDEN DEATH;
SURGICAL APPROACH;
SURGICAL MORTALITY;
SURVIVAL;
SYNCOPE;
CARDIOMYOPATHY, HYPERTROPHIC;
ECHOCARDIOGRAPHY;
ETHANOL;
EXERCISE TEST;
HEART CATHETERIZATION;
HEART SEPTUM;
HUMANS;
|
|
EID: 0034036704
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1053/euhj.1999.2019 Document Type: Editorial |
|
Times cited : (27)
|
|
References (11)
|
